AbbVie (ABBV) Change in Receivables (2012 - 2026)
AbbVie (ABBV) reported Change in Receivables of -$87.0 million for Q1 2026, down 105.88% year-over-year from $1.5 billion in Q1 2025, and up 46.3% on a QoQ basis from -$162.0 million in Q4 2025.
AbbVie (ABBV) has 15 years of Change in Receivables data on file, last reported at -$87.0 million in Q1 2026.
- Quarterly Change in Receivables fell 105.88% year-over-year to -$87.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.0 million (down 113.33% YoY) and the FY2025 annual result came in at $1.5 billion, up 819.81% from the prior year.
- Change in Receivables grew to -$87.0 million in Q1 2026 per ABBV's latest filing, from -$162.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.5 billion in Q1 2025 and bottomed at -$387.0 million in Q4 2024.
- The 5-year median for Change in Receivables is $17.0 million (2025), against an average of $152.1 million.
- Peak annual rise in Change in Receivables reached 260.0% in 2024, while the deepest fall reached 17100.0% in 2024.
- Tracing ABBV's Change in Receivables over 5 years: stood at $416.0 million in 2022, then tumbled by 181.49% to -$339.0 million in 2023, then slipped by 14.16% to -$387.0 million in 2024, then surged by 58.14% to -$162.0 million in 2025, then surged by 46.3% to -$87.0 million in 2026.
- Per Business Quant, the three latest ABBV Change in Receivables figures stand at -$87.0 million (Q1 2026), -$162.0 million (Q4 2025), and $156.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | -504.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 595.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -87.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -413.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -134.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.69 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.00 Mn |
| Mar 31, 2026 | -87.00 Mn |
| Dec 31, 2025 | -162.00 Mn |
| Dec 31, 2025 | -162.00 Mn |
| Sep 30, 2025 | 156.00 Mn |
| Sep 30, 2025 | 156.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Mar 31, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | -387.00 Mn |
| Dec 31, 2024 | -387.00 Mn |
| Sep 30, 2024 | -344.00 Mn |
| Sep 30, 2024 | -344.00 Mn |
| Jun 30, 2024 | -178.00 Mn |
| Jun 30, 2024 | -178.00 Mn |
| Mar 31, 2024 | 702.00 Mn |
| Mar 31, 2024 | 702.00 Mn |
| Dec 31, 2023 | -339.00 Mn |
| Dec 31, 2023 | -339.00 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | 80.00 Mn |
| Jun 30, 2023 | 80.00 Mn |
| Mar 31, 2023 | 195.00 Mn |
| Mar 31, 2023 | 195.00 Mn |
| Dec 31, 2022 | 416.00 Mn |
| Dec 31, 2022 | 416.00 Mn |
| Sep 30, 2022 | -357.00 Mn |
| Sep 30, 2022 | -357.00 Mn |
| Jun 30, 2022 | 611.00 Mn |
| Jun 30, 2022 | 611.00 Mn |
| Mar 31, 2022 | 785.00 Mn |
| Mar 31, 2022 | 785.00 Mn |
| Dec 31, 2021 | 749.00 Mn |
| Dec 31, 2021 | 749.00 Mn |
| Sep 30, 2021 | -590.00 Mn |
| Sep 30, 2021 | -590.00 Mn |
| Jun 30, 2021 | 296.00 Mn |
| Jun 30, 2021 | 296.00 Mn |
| Mar 31, 2021 | 866.00 Mn |
| Mar 31, 2021 | 866.00 Mn |
| Dec 31, 2020 | 355.00 Mn |
| Dec 31, 2020 | 355.00 Mn |
| Sep 30, 2020 | 31.00 Mn |
| Sep 30, 2020 | 31.00 Mn |
| Jun 30, 2020 | -482.00 Mn |
| Jun 30, 2020 | -482.00 Mn |
| Mar 31, 2020 | 1.03 Bn |
| Mar 31, 2020 | 1.03 Bn |
| Dec 31, 2019 | -133.00 Mn |
| Dec 31, 2019 | -133.00 Mn |
| Sep 30, 2019 | 111.00 Mn |
| Sep 30, 2019 | 111.00 Mn |
| Jun 30, 2019 | -220.00 Mn |
| Jun 30, 2019 | -220.00 Mn |
| Mar 31, 2019 | 316.00 Mn |
| Mar 31, 2019 | 316.00 Mn |
| Dec 31, 2018 | -215.00 Mn |
| Dec 31, 2018 | -215.00 Mn |
| Sep 30, 2018 | 1.00 Mn |
| Sep 30, 2018 | 1.00 Mn |
| Jun 30, 2018 | 124.00 Mn |
| Jun 30, 2018 | 124.00 Mn |
| Mar 31, 2018 | 681.00 Mn |
| Mar 31, 2018 | 681.00 Mn |
| Dec 31, 2017 | 228.00 Mn |
| Dec 31, 2017 | 228.00 Mn |
| Sep 30, 2017 | -4.00 Mn |
| Sep 30, 2017 | -4.00 Mn |
| Jun 30, 2017 | 133.00 Mn |
| Jun 30, 2017 | 133.00 Mn |
| Mar 31, 2017 | 34.00 Mn |
| Mar 31, 2017 | 34.00 Mn |
| Dec 31, 2016 | -58.00 Mn |
| Dec 31, 2016 | -58.00 Mn |
| Sep 30, 2016 | -65.00 Mn |
| Sep 30, 2016 | -65.00 Mn |
| Jun 30, 2016 | 275.00 Mn |
| Jun 30, 2016 | 275.00 Mn |
| Mar 31, 2016 | -81.00 Mn |
| Mar 31, 2016 | -81.00 Mn |
| Dec 31, 2015 | 234.00 Mn |
| Dec 31, 2015 | 234.00 Mn |
| Sep 30, 2015 | 254.00 Mn |
| Sep 30, 2015 | 254.00 Mn |
| Jun 30, 2015 | 44.00 Mn |
| Jun 30, 2015 | 44.00 Mn |
| Mar 31, 2015 | 544.00 Mn |
| Mar 31, 2015 | 544.00 Mn |
| Dec 31, 2014 | 267.00 Mn |
| Dec 31, 2014 | 267.00 Mn |
| Sep 30, 2014 | 25.00 Mn |
| Sep 30, 2014 | 25.00 Mn |
| Jun 30, 2014 | 47.00 Mn |
| Jun 30, 2014 | 47.00 Mn |
| Mar 31, 2014 | -167.00 Mn |
| Mar 31, 2014 | -167.00 Mn |
| Dec 31, 2013 | -27.00 Mn |
| Dec 31, 2013 | -27.00 Mn |
| Sep 30, 2013 | -69.00 Mn |
| Sep 30, 2013 | -69.00 Mn |
| Jun 30, 2013 | -528.00 Mn |
| Jun 30, 2013 | -528.00 Mn |
| Mar 31, 2013 | -57.00 Mn |
| Mar 31, 2013 | -57.00 Mn |
| Dec 31, 2012 | 490.00 Mn |
| Dec 31, 2012 | 490.00 Mn |
| Sep 30, 2012 | 39.00 Mn |
| Sep 30, 2012 | 39.00 Mn |
| Jun 30, 2012 | -531.00 Mn |
| Jun 30, 2012 | -531.00 Mn |
| Mar 31, 2012 | -221.00 Mn |
| Mar 31, 2012 | -221.00 Mn |